Warning message

ARCHIVED CONTENT: Persons using assistive technology may not be able to fully access information in this file. For assistance, please send an email to niaic@nia.nih.gov or call us at 1-800-222-2225.
About NIA

NACA Meeting: September 18-19, 2012

National Advisory Council on Aging Meeting Agenda -- September 2012

One Hundred-Seventeenth Meeting
Tuesday and Wednesday, September 18-19, 2012
Building 31, 6th Floor, C Wing, Conference Room 10
Day-of-the-Meeting Contact Phone: 301-402-8710

TUESDAY, September 18

3:00 to 5:00 p.m. – This portion of the meeting is closed to the Public

This portion of the meeting is closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S. Code and Section 10(d) of the Federal Advisory Committee Act as amended (5 U.S.C. Appendix 2).

Review of Applications: Dr. Robin Barr

WEDNESDAY, September 19

8:00 to 8:45 a.m. - This portion of the meeting is open to the Public

  1. Call to Order
    Dr. Richard Hodes
    1. Director’s Status Report
    2. Future Meeting Dates:

      January 29-30, 2013 (Tue.-Wed.)
      June 4-5, 2013 (Tue.-Wed.)
      September 17-18, 2013 (Tue.-Wed.)
      February 25-26, 2014 (Tue.-Wed.)

    3. Consideration of Minutes of Last Meeting

8:45 to 9:15 a.m.

  1. Report: Task Force on Minority Aging Research
    Dr. Eliseo Perez-Stable

9:15 to 9:25 a.m.

  1. Report: Council of Councils
    Dr. Terrie Wetle

9:25 to 10:25 a.m.

  1. Report: Working Group on Program
    1. Scheduling Initiatives in FY 2013 - An Uncertain Year - Dr. Hodes
    2. Advisory Workshops
      Recommendations from Past Meetings
    3. Forthcoming Meetings
    4. FOA/RFA Concept Clearance
      • Age-Related Changes in Osteoimmunology: an Integrative Physiological Approach – Dr. John P. Williams (DAB)
      • Genetic Analysis – DN Staff
      • Target Identification and Validation – DN Staff
      • Phase I Clinical Trials for AD Therapeutics – DN Staff
      • BluePrint Neurotherapeutics – DN Staff
      • Prevention Trials – DN Staff
      • Drug Discovery Training for Academic Scientists – DN Staff
      • Preclinical Animal Model Testing – DN Staff
      • Preclinical Testing Data Repository – DN Staff
    5. Status Report of the German Center for Neurodegenerative
      Diseases (DZNE)

10:25 to 10:45 a.m.

  1. Comments from retiring Council Members
    Drs. LaCroix, Molinari, Mucke and Ms. Simmons

10:45 to 11:00 a.m.


11:00 to 12:00 p.m.

  1. Program Highlights

11:00 to 11:30 p.m.

  1. Program Highlights (DAB):
    Dr. Felipe Sierra
    “Energy Metabolism, Tissue Homeostasis Longevity” David W. Walker, Ph.D., University of California – Los Angeles, Department of Integrative Biology and Physiology

11:30 to 12:00 p.m.

  1. Program Highlights (DN):
    Dr. Stephen Snyder
    “An Integrated Approach to Understanding Cognitive Aging: Implication for Identifying Novel Therapeutic Targets” David A. Bennett, M.D., Director, Rush Alzheimer’s Disease Center, Rush University Medical Center

12:00 to 12:15 p.m.


12:15 to 1:15 p.m.

  1. Working Lunch: Program Highlights (DGCG):
    Dr. Evan Hadley
    “Maximizing the Benefits of Prevention by Considering Life Expectancy and Lagtime to Benefit” Dr. Sei Lee, Assistant Professor, University of California, San Francisco, San Francisco VA, Division of Geriatrics

12:45 to 1:15 p.m.

  1. Working Lunch: Program Highlights (DBSR):
    Dr. Richard Suzman
    “Technology Growth and Expenditure Growth in the U.S. Healthcare” Dr. Jonathan Skinner, Professor of Community and Family Medicine, Dartmouth College

1:15 p.m.

  1. Adjournment